These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [The plasma levels and diagnostic utility of granulocyte-colony stimulating factor (G-CSF) and granulocyte-macrophage - colony stimulating factor (GM-CSF) in patients with I and II stage of breast cancer]. Ławicki S, Czygier M, Wojtukiewicz M, Szmitkowski M. Przegl Lek; 2009; 66(7):365-9. PubMed ID: 20043577 [Abstract] [Full Text] [Related]
5. [The plasma levels and diagnostic utility of granulocyte colony stimulating factor (G-CSF) and macrophage - colony stimulating factor (M-CSF) in ovarian cancer patients]. ławicki S, Czygier M, Gacuta-Szumarska E, Knapp P, Szmitkowski M. Pol Merkur Lekarski; 2006 Nov; 21(125):465-8. PubMed ID: 17345841 [Abstract] [Full Text] [Related]
6. Plasma Levels and Diagnostic Utility of M-CSF, MMP-2 and its Inhibitor TIMP-2 in the Diagnostics of Breast Cancer Patients. Ławicki S, Zajkowska M, Głażewska EK, Będkowska GE, Szmitkowski M. Clin Lab; 2016 Sep 01; 62(9):1661-1669. PubMed ID: 28164586 [Abstract] [Full Text] [Related]
7. [The plasma levels of granulocyte-colony stimulating factor (G-CSF) and macrophage-colony stimulating factor (M-CSF) in breast cancer patients]. Lawicki S, Czygier M, Omyła J, Szmitkowski M. Pol Arch Med Wewn; 2006 Aug 01; 116(2):749-55. PubMed ID: 17424919 [Abstract] [Full Text] [Related]
14. [The plasma levels of granulocyte-colony stimulating factor and granulocyte-macrophage colony stimulating factor in breast cancer patients]. Ławicki S, Czygier M, Omyła J, Bedkowska E, Szmitkowski M. Pol Merkur Lekarski; 2007 Oct 01; 23(136):259-63. PubMed ID: 18293847 [Abstract] [Full Text] [Related]
15. [The plasma levels and diagnostic utility of stem cell factor and macrophage--colony stimulating factor in endometrial cancer patients]. Lawicki S, Bedkowska E, Gacuta-Szumarska E, Czygier M, Szmitkowski M. Przegl Lek; 2007 Oct 01; 64(12):987-90. PubMed ID: 18595499 [Abstract] [Full Text] [Related]
16. Granulocyte-Colony stimulating factor and macrophage-colony stimulating factor in patients with non-small-cell lung cancer. Mroczko B, Szmitkowski M, Niklinski J. Clin Chem Lab Med; 2001 May 01; 39(5):374-9. PubMed ID: 11434384 [Abstract] [Full Text] [Related]
17. Diagnostic Power of Vascular Endothelial Growth Factor and Macrophage Colony-Stimulating Factor in Breast Cancer Patients Based on ROC Analysis. Zajkowska M, Głażewska EK, Będkowska GE, Chorąży P, Szmitkowski M, Ławicki S. Mediators Inflamm; 2016 May 01; 2016():5962946. PubMed ID: 27445439 [Abstract] [Full Text] [Related]
18. VEGF, M-CSF and CA 15-3 as a new tumor marker panel in breast malignancies: a multivariate analysis with ROC curve. Ławicki S, Będkowska GE, Szmitkowski M. Growth Factors; 2013 Jun 01; 31(3):98-105. PubMed ID: 23688065 [Abstract] [Full Text] [Related]
19. Plasma levels and diagnostic utility of macrophage-colony stimulating factor, matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 as tumor markers in cervical cancer patients. Zajkowska M, Zbucka-Krętowska M, Sidorkiewicz I, Lubowicka E, Gacuta E, Szmitkowski M, Chrostek L, Ławicki S. Tumour Biol; 2018 Jul 01; 40(7):1010428318790363. PubMed ID: 30052166 [Abstract] [Full Text] [Related]